Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Gabriele Luppi, Jean‐Frédéric Blanc et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 61
Circulating cell-free DNA in patients with alveolar echinococcosisAlice Baraquin, Nicolas Lefèbvre, Paul Peixoto et al.|Molecular and Biochemical Parasitology|2018Cited by 29